Last updated on April 2019

Loose-dose Combination of Acarbose and Metformin for T2DM in Metformin-failure Patients


Brief description of study

To demonstrate the efficacy and safety of acarbose and metformin loose-dose combination as compared to metformin monotherapy in the treatment of subjects with T2DM that is inadequately controlled by metformin alone

Clinical Study Identifier: NCT03349684

Recruitment Status: Closed


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.